Buckingham Strategic Wealth’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,710
| Closed | -$232K | – | 769 |
|
|
2024
Q1 | $232K | Hold |
13,710
| – | – | ﹤0.01% | 665 |
|
|
2023
Q4 | $194K | Sell |
13,710
-800
| -6% | -$11.3K | ﹤0.01% | 681 |
|
|
2023
Q3 | $149K | Buy |
14,510
+800
| +6% | +$8.24K | ﹤0.01% | 647 |
|
|
2023
Q2 | $226K | Hold |
13,710
| – | – | ﹤0.01% | 597 |
|
|
2023
Q1 | $98.2K | Hold |
13,710
| – | – | ﹤0.01% | 587 |
|
|
2022
Q4 | $98.2K | Hold |
13,710
| – | – | ﹤0.01% | 589 |
|
|
2022
Q3 | $69K | Hold |
13,710
| – | – | ﹤0.01% | 576 |
|
|
2022
Q2 | $33K | Hold |
13,710
| – | – | ﹤0.01% | 593 |
|
|
2022
Q1 | $94K | Hold |
13,710
| – | – | ﹤0.01% | 580 |
|
|
2021
Q4 | $111K | Hold |
13,710
| – | – | ﹤0.01% | 579 |
|
|
2021
Q3 | $134K | Hold |
13,710
| – | – | ﹤0.01% | 574 |
|
|
2021
Q2 | $92K | Hold |
13,710
| – | – | ﹤0.01% | 578 |
|
|
2021
Q1 | $124K | Hold |
13,710
| – | – | 0.01% | 532 |
|
|
2020
Q4 | $92K | Buy |
+13,710
| New | +$92K | ﹤0.01% | 522 |
|